Drug Fix: Innovation v. Access, AAM CEO Departs, Concerns About US FDA’s IND Regulations

Pink Sheet reporters and editor consider the line between therapeutic innovation and affordability, the Association for Accessible Medicines searching for a new CEO, and questions about IND regulations and drug repurposing.